13Nov Mankind Pharma submits analyst meet inPursuant to Regulation 30 read with Part A of Schedule III of the Securi..
07Nov Mankind Pharma reports 21% fall in Q2 Mankind Pharma has reported result for second quarter ended September 30..
29Oct Mankind Pharma informs about earnings Pursuant to Regulation 30 & 51 of the SEBI (Listing Obligations and..
13Oct Mankind Pharma inks pact to acquire WoMankind Pharma has executed a Business Transfer Agreement (BTA) with its..
08Sep Mankind rises on getting CDSCO’s approMankind Pharma is currently trading at Rs. 2575.55, up by 24.05 points o..